AminoChain
New York, US · Founded 2022 · Delaware corporation · 5 known investors
AminoChain builds decentralized infrastructure for biomedical research that connects biospecimens, participant consent, and research data through a network of biorepositories. The platform provides AI-powered search for biospecimens and participant management systems for prospective research studies.
Founders & leadership
CB
Caspar BarnesExecutive Officer, Director
MC
Michael CalveyDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$7.1MraisedAug 2024 · 21 investors · OtherRule 506(b)
▶$7.1MraisedAug 2024 · 21 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Caspar BarnesExecutive Officer, Director
- Michael CalveyDirector
- Offering amount
- $7.7M
- Amount sold
- $7.1M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- AminoChain Secured $7 Million Funding to Revolutionize Biobanking with Blockchain Technology - Biobanking.combiobanking.com · 2024
- AminoChain Raises $5M in Seed Fundingfinsmes.com · 2024
- A16z makes first 'DeSci' investment in decentralized biobank platform AminoChain | The Blocktheblock.co · 2024
- a16z begins investing in DeSci with AminoChain, leads $5M seed roundcryptobriefing.com · 2024